Recalling firm
Amerisource Health Services LLC
Product type
Drug
Status
Terminated
Report date
2025-01-22
Distribution
Nationwide in the USA
Firm state
OH
Product quantity
2,028 units (cartons of 30 individual unit doses)
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Validation & QualificationReason for recall
Failed Dissolution Specifications:
Product description
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Code / lot info
Lot # 1012910, Exp Date: 04/30/2025
Other recalls SPEQ maps to Validation & Qualification
See all Validation & Qualification recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.